THAT — Thalia Therapeutics Share News
0.000.00%
Last trade - 00:00- £11.10m
- £9.59m
- £0.01m
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results
Thalia Therapeutics - Holding(s) in Company
Thalia Therapeutics - Holding(s) in Company
Thalia Therapeutics - Grant of Director Share Options
Thalia Therapeutics - Holding(s) in Company
Thalia Therapeutics - Holding(s) in Company
Thalia Therapeutics - Holding(s) in Company
Thalia Therapeutics - AGM Statement
Thalia Therapeutics - Posting of Annual Report and Notice of AGM
Brief: Thalia Therapeutics To Buy Sanmirna Therapeutics For Clinical-Stage AML RNA Therapy
Thalia Therapeutics - Acquisition and £2.75 million Fundraise
Thalia Therapeutics - Final Results
RCS - Thalia Therapeutics - New article: RNA medicine enters its second act
RCS - Thalia Therapeutics - CEO Interview
RCS - Thalia Therapeutics - CEO Interview: Thalia’s RNA Therapeutics Strategy
Brief: N4 Pharma Shareholders Pass Resolution To Change Co Name To Thalia Therapeutics